This PATH Blog post examines PATH’s work in malaria through OneWorld Health, a non-profit drug development program. Since 2004, “when OneWorld Health formed a partnership to develop an alternative source of the malaria drug artemisinin, … OneWorld Health, which became an affiliate of PATH late last year, [has] quietly forged relationships with public and private partners, creating the Artemisinin Project to take the work from research to commercialization,” the blog writes. “Supported by the Bill & Melinda Gates Foundation, the partners worked toward providing an affordable and reliable source of high-quality artemisinin — one not dependent on planting schedules, the weather, or the fluctuating market,” the blog adds (Donnelly, 4/10).